• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热熔挤出醋氯芬酸-固体分散体:增强溶出度的混溶性及药物-载体相互作用的机理研究

Hot Melt Extruded Aceclofenac-Soluplus® Solid Dispersion: Mechanistic View of Miscibility and Drug-Carrier Interactions for Enhanced Dissolution.

作者信息

U Likhitha, Bharti Roushan, Narayan Reema, Mehta Chetan H, Nayak Usha Yogendra

机构信息

Center for Drug Delivery Technologies, Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.

出版信息

AAPS PharmSciTech. 2025 Jul 1;26(6):180. doi: 10.1208/s12249-025-03173-w.

DOI:10.1208/s12249-025-03173-w
PMID:40593154
Abstract

Aceclofenac (ACF), a Non-Steroidal Anti-Inflammatory Drug (NSAID), is formulated with Soluplus® (SOLP) to enhance solubility and bioavailability. This study presents a distinct approach by utilizing Hot Melt Extrusion (HME) to prepare Aceclofenac-Soluplus® solid dispersion (ACF-SOLP), in contrast to the previously investigated nanoemulsion technique. The HME technique facilitates a uniform drug distribution within the polymer matrix, increasing ACF's dissolution rate. Different weight ratios of ACF and SOLP were assessed with 1:8 (HM4), which proved to be the optimal choice. ACF is dispersed within SOLP in its amorphous state, and HM4 exhibited a significant increase in drug release as compared to pure ACF and its physical mixture. In vivo pharmacokinetic data of HM4 demonstrated a drastic improvement in the C (7.1 ± 0.14 µg/ml) and AUC (12.1 ± 1.30 µg-h/ml). Further, molecular dynamics simulation revealed that the polymer is widely dispersed within the supramolecular architecture of ACF-SOLP, with ACF positioned centrally, confirming the favorable interactions between the components. Leveraging the hydrophilic nature of the SOLP, the solid dispersion demonstrated enhanced dissolution of ACF, while HME synergistically reinforced the combination. This approach presents a compelling alternative to traditional methods, unlocking new possibilities for formulating poorly soluble drugs.

摘要

醋氯芬酸(ACF)是一种非甾体抗炎药(NSAID),与Solupuls®(SOLP)一起制成制剂以提高溶解度和生物利用度。本研究提出了一种独特的方法,即利用热熔挤出(HME)技术制备醋氯芬酸 - Solupuls®固体分散体(ACF - SOLP),这与之前研究的纳米乳液技术不同。HME技术有助于药物在聚合物基质中均匀分布,提高ACF的溶解速率。评估了ACF和SOLP的不同重量比,其中1:8(HM4)被证明是最佳选择。ACF以无定形状态分散在SOLP中,与纯ACF及其物理混合物相比,HM4的药物释放显著增加。HM4的体内药代动力学数据表明,其C(7.1±0.14μg/ml)和AUC(12.1±1.30μg - h/ml)有显著改善。此外,分子动力学模拟表明,聚合物广泛分散在ACF - SOLP的超分子结构中,ACF位于中心位置,证实了各组分之间的良好相互作用。利用SOLP的亲水性,固体分散体显示出ACF的溶解增强,而HME协同增强了这种组合。这种方法为传统方法提供了一种有吸引力的替代方案,为难溶性药物的制剂开发开辟了新的可能性。

相似文献

1
Hot Melt Extruded Aceclofenac-Soluplus® Solid Dispersion: Mechanistic View of Miscibility and Drug-Carrier Interactions for Enhanced Dissolution.热熔挤出醋氯芬酸-固体分散体:增强溶出度的混溶性及药物-载体相互作用的机理研究
AAPS PharmSciTech. 2025 Jul 1;26(6):180. doi: 10.1208/s12249-025-03173-w.
2
Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.五阶段方法通过热熔挤出法对依曲韦林无定形固体分散体进行系统筛选和开发。
Mol Pharm. 2020 Feb 3;17(2):554-568. doi: 10.1021/acs.molpharmaceut.9b00996. Epub 2020 Jan 23.
3
Slurry Conversion: A General Method for Formulating Amorphous Solid Dispersions and Fully Integrating Drug and Polymer Components.浆液转化法:一种制备无定形固体分散体并使药物与聚合物成分充分整合的通用方法。
Mol Pharm. 2025 Jul 7;22(7):3976-3986. doi: 10.1021/acs.molpharmaceut.5c00240. Epub 2025 Jun 13.
4
Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.采用配备双螺杆系统的热熔挤出法制备的基于Soluplus®/TPGS的固体分散体,用于提高缬沙坦的口服生物利用度。
Drug Des Devel Ther. 2015 May 22;9:2745-56. doi: 10.2147/DDDT.S84070. eCollection 2015.
5
Development of Hot Melt Extruded Co-Formulated Artesunate and Amodiaquine- Soluplus Solid Dispersion System in Fixed-Dose Form: Amorphous State Characterization and Pharmacokinetic Evaluation.热熔挤出共配制青蒿琥酯和阿莫地喹 - Soluplus 固体分散体系统的固定剂量剂型开发:非晶态表征与药代动力学评价。
Curr Drug Metab. 2024;25(7):505-522. doi: 10.2174/0113892002330772240912055518.
6
Vertical Hot-Melt Extrusion: The Next Challenge in Innovation.垂直热熔挤出:创新中的下一个挑战。
Pharmaceutics. 2025 Jul 21;17(7):939. doi: 10.3390/pharmaceutics17070939.
7
Sustained release dosage form of noscapine HCl using hot melt extrusion (HME) technique: formulation and pharmacokinetics.盐酸纳布啡热熔挤出(HME)技术的控释制剂:配方和药代动力学。
Drug Deliv Transl Res. 2021 Jun;11(3):1156-1165. doi: 10.1007/s13346-020-00838-w.
8
Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.洛匹那韦固体分散体增溶和生物利用度研究-聚合物表面活性剂 Soluplus 基质。
Eur J Pharm Sci. 2019 Jun 15;134:233-245. doi: 10.1016/j.ejps.2019.04.022. Epub 2019 Apr 24.
9
Hot Melt Extrusion Technology in Taste Masking.热熔挤出技术在掩味中的应用
AAPS PharmSciTech. 2025 Jul 22;26(7):196. doi: 10.1208/s12249-025-03174-9.
10
Enhancing gliclazide solubility using solid dispersions with carboxymethyl chitosan and polyvinylpyrrolidone K30 as polymeric carriers.以羧甲基壳聚糖和聚乙烯吡咯烷酮K30为聚合物载体,通过固体分散体提高格列齐特的溶解度。
Drug Dev Ind Pharm. 2025 Jul;51(7):735-746. doi: 10.1080/03639045.2025.2506651. Epub 2025 May 28.

本文引用的文献

1
Development of Hot Melt Extruded Co-Formulated Artesunate and Amodiaquine- Soluplus Solid Dispersion System in Fixed-Dose Form: Amorphous State Characterization and Pharmacokinetic Evaluation.热熔挤出共配制青蒿琥酯和阿莫地喹 - Soluplus 固体分散体系统的固定剂量剂型开发:非晶态表征与药代动力学评价。
Curr Drug Metab. 2024;25(7):505-522. doi: 10.2174/0113892002330772240912055518.
2
Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies.热熔挤出原位凝胶系统(MeltDrops 技术):制剂开发、计算机模拟和体内研究。
Eur J Pharm Biopharm. 2023 Jul;188:108-124. doi: 10.1016/j.ejpb.2023.05.008. Epub 2023 May 12.
3
Application of HPMC HME polymer as hot melt extrusion carrier in carbamazepine solid dispersion.
羟丙甲纤维素 HME 聚合物在卡马西平固体分散体热熔挤出载体中的应用。
Drug Dev Ind Pharm. 2020 Dec;46(12):1911-1918. doi: 10.1080/03639045.2020.1821045. Epub 2020 Nov 13.
4
Surface Solid Dispersion and Solid Dispersion of Meloxicam: Comparison and Product Development.美洛昔康的表面固体分散体和固体分散体:比较与产品开发
Adv Pharm Bull. 2017 Dec;7(4):569-577. doi: 10.15171/apb.2017.068. Epub 2017 Dec 31.
5
Enhancement of solubility and bioavailability of ambrisentan by solid dispersion using Daucus carota as a drug carrier: formulation, characterization, in vitro, and in vivo study.采用胡萝卜作为药物载体的固体分散体提高安贝生坦的溶解度和生物利用度:制剂、表征、体外和体内研究。
Drug Dev Ind Pharm. 2018 Jun;44(6):1001-1011. doi: 10.1080/03639045.2018.1428339. Epub 2018 Feb 5.
6
A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies.一种提高醋氯芬酸溶解度和生物利用度的自上而下技术:体外和体内研究
Int J Nanomedicine. 2017 Jul 11;12:4921-4935. doi: 10.2147/IJN.S141504. eCollection 2017.
7
On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.关于 Soluplus 固有性质及其在微波淬火冷却技术制备布洛芬固体分散体中的应用。
Pharm Dev Technol. 2018 Jul;23(6):573-586. doi: 10.1080/10837450.2016.1256409. Epub 2016 Nov 16.
8
Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.聚合物无定形固体分散体:生物药剂学分类系统II类药物的非晶化、结晶、稳定化、固态表征及水相增溶综述
J Pharm Sci. 2016 Sep;105(9):2527-2544. doi: 10.1016/j.xphs.2015.10.008. Epub 2016 Jan 23.
9
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.非晶态固体分散体热加工中的挑战与策略:综述
AAPS PharmSciTech. 2016 Feb;17(1):43-55. doi: 10.1208/s12249-015-0393-y. Epub 2015 Aug 26.
10
Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development.无定形固体分散体:药物研发中的应用与挑战
J Pharm Sci. 2015 Oct;104(10):3237-58. doi: 10.1002/jps.24541. Epub 2015 Jul 14.